Annemie Bogaerts (born 25 October 1971)[1] is a Belgian chemist known for her work in plasma chemistry, plasma-based green chemistry, which include amongst others CO2 conversion, CH4 conversion for H2 synthesis or the synthesis of hydrocarbons and N2 fixation as basis for fertilizer production, as well as for her work in plasma medicine for cancer treatment, and the use of laser ablation to sample chemicals and form plasmas.
[2] Bogaerts is originally from Wilrijk, a district of Antwerp.
[3] She studied chemistry at the University of Antwerp, earning a master's degree there in 1993 and completing her Ph.D. in 1996.
[1] She is head of the research group PLASMANT, and co-founder of two spin-off companies, D-CRBN[4] and Optanic, based on the research of her group PLASMANT on using plasma technology for CO2 conversion and for dry reforming of methane, respectively.
[6] She was Francqui Distinguished Research Professor (2013-2016) and is the recipient of a prestigious European Research Council (ERC) Synergy Grant[7] (2019-2025) on plasma-based electrification of chemical reactions, with Gabriel Centi, Volker Hessel and Evgenii Rebrov.